BioWorld MedTech

Sep. 25, 2013

AdvaMed 2013: Market projected to achieve global sales of $455B in 2018

WASHINGTON — While 2013 has been a rough year for the med-tech market, a report from EvaluateMedTech forecasts happier days ahead, with the industry approaching $455 billion in global sales in 2018. Read More

AdvaMed 2013: Silverman; measures tough to come by for quality initiative

FDA revises Sapien labeling, expanding patient population

Solana launches FuseFORCE SuperElastic fixation system

Report from Europe: LabStyle gets CE mark for its Dario glucose monitor

Deals roundup: Greenway acquires Vitera in transaction for $644 million

Patent watch: HiberGene Diagnostics secures patent for Meningoccus test

People in Places

Financings roundup: Ventas reveals pricing of senior notes offering

Agreements/contracts: Piedmont Healthcare, Vanderbilt in pact to deploy CaseXpertSM

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 15, 2026.

AI-generated illustration of a neuron with tau protein aggregation

AAIC 2026: Age of amyloid is being joined by time of tau

BioWorld

The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...

Celia trial: data strong, analysts skeptical

BioWorld

Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 14, 2026

Photo of scale with woman sitting on floor holding head and arms on knees

Rethinking anorexia: A disorder of mind and metabolism

BioWorld Science

Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...